Σellas Medical Devices engages in the development and distribution of innovative medical devices, aiming at a leading position in this niche market of the healthcare sector.
We focus, amongst others, on non/invasive neuromodulatory medical devices. Neuromodulation includes treatments that involve the stimulation of various nerves of the central, peripheral, and autonomic nervous system, as well as deep brain nuclei thus altering neuronal function and improving symptoms.
Σellas Medical Devices entered the global neuromodulation device market by currently developing an innovative product that utilizes neurostimulation through two distinct cranial nerves. This device introduces a pioneering way of treating, non invasively up to five serious , conditions transcutaneously, where standard treatments have not succeeded to achieve satisfactory clinical outcomes.
The company offers a complete spectrum of services regarding this sort of devices, including concept development, technical production, clinical trials and official market launch. Our devices are developed under the strictest regulations to comply with the highest requirements set by top health authorities in order to obtain advanced international certifications.
The development of these medical devices is being conducted in collaboration with well-known companies in Europe and the US. The patent is under filing and waiting for approval.
More information will be released soon.